Pathophysiology and treatment of ascites and the hepatorenal syndrome
- 1 September 1992
- journal article
- review article
- Published by Elsevier in Bailliere's Clinical Gastroenterology
- Vol. 6 (3) , 581-607
- https://doi.org/10.1016/0950-3528(92)90040-l
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Sodium Retention in Cirrhosis: Aspects of Pathophysiology and Treatment1Published by S. Karger AG ,2015
- Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascitesGastroenterology, 1991
- Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administrationJournal of Hepatology, 1990
- Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic ratsGastroenterology, 1989
- Renal Functional Impairment and Sodium Retention in Liver CirrhosisDigestion, 1989
- Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosisPublished by Elsevier ,1988
- Pathophysiology of ascites and functional renal failure in cirrhosisJournal of Hepatology, 1988
- Increased levels of platelet‐activating factor in blood from patients with cirrhosis of the liverEuropean Journal of Clinical Investigation, 1987
- Compensated cirrhosis: Natural history and prognostic factorsHepatology, 1987
- Role of Vasopressin in Abnormal Water Excretion in Cirrhotic PatientsAnnals of Internal Medicine, 1982